Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: isa walter who wrote (9895)	7/26/1998 11:23:00 AM
From: Keiko	Read Replies (2) \| Respond to of 14328

Guten Tag Mein Herr * A sincere and warm welcome from all of us here at the Celtic Persuasion. We always welcome new visitors especially from the Land of Bratwurst and Weinersnitzel.......not to mention our new corporate partners......Mercedes Benz/ Chrysler. Your mention of Chronic Fatique Syndrome ( CFS ) reminds me of a recent event which took place....Trinity is just now entering these test markets and Trinity's corporate partner ( Wampole Labs ) has been attempting to acquire new plate technologies in this area...( EBV ) There have been rumors circulating that Wampole will soon make a move on Gull Labs ( GUL ) and Gull is ripe for the picking as its stock price has been battered down into the $ 3.00 range after being as high as $ 13.00 this past year. GULL has leading edge technology and very valuable licenses for the EIA plate tests in the Epstein Barr Virus , a widely and sometimes deadly virus that plaques man around the world...Mono and shingles......CFS and others. just to name a few....... Welcome aboard....pull up a chair and lets chew the fat. &&&& ...... Keiko ps .....Trinity has a very strong marketing agreement with " Merlin " in Germany and that seems to be going along very nicely.

To: isa walter who wrote (9895)	7/26/1998 2:21:00 PM
From: Ace	Read Replies (1) \| Respond to of 14328

Isa we certainly could use a recommendation from a firm like Biovest. We only have one now and I believe it is from Sanjay Jain who last did a report May 1, 1997. At that time Triby was raised to a Buy rating from accumulate. Pershing did a report , February 1997. LongVeiw did a report , April 1997